Skip to main content
SpringerLink
Log in
Book cover

Infectious Causes of Cancer pp 93–111Cite as

Epstein-Barr Virus and Nasopharyngeal Carcinoma

  • Chapter

  • 232 Accesses

Part of the book series: Infectious Disease ((ID))

Abstract

The Epstein—Barr virus (EBV) is associated with malignancies that arise in both B lymphocytes and epithelial cells, including Burkitt’s lymphoma, immunodeficiency-related lymphoma, and nasopharyngeal carcinoma (NPC) (1,2). The malignancies associated with EBV develop years postinfection, suggesting that they represent some form of reactivated infection.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Raab-Traub N. Epstein—Barr virus and nasopharyngeal carcinoma. In: Rickinson A (eds). Seminars in Cancer Biology. Saunders Scientific Publishers, Academic Press, London, 1993, pp. 297–303.

    Google Scholar 

  2. Rickinson AB, Kieff E. In: Fields BN, Knipe DM, Howley PM (eds). Fields Virology, 3rd,edit., Vol. 2. Philadelphia: Lippincott-Raven, 1996, pp. 2397–2476.

    Google Scholar 

  3. de Thé G. Epidemiology of Epstein—Barr virus and associated diseases. In: Roizman B(eds). The Herpesviruses. New York: Plenum Press, 1982, pp. 25–87.

    Chapter  Google Scholar 

  4. Ho JHC. Epidemiology of nasopharyngeal carcinoma (NPC). In: Ablashi DV, Huang AT, Pagano JS, Pearson GR, Yang CS (eds). Epstein—Barr virus and Human Disease. Humana Press, Totowa, NJ, 1990, pp. xli–xliv.

    Google Scholar 

  5. Pathmanathan R. Pathology. In: Chong VFH, Tsao SY (eds). Nasopharyngeal Carcinoma. Singapore: Armour, 1997, pp. 6–13.

    Google Scholar 

  6. Shanmugaratnam K, Chan SH, de Thé G, et al. Histopathology of nasopharyngeal carcinoma. Cancer 1979; 44: 1029–1044.

    Article  PubMed  CAS  Google Scholar 

  7. Henle G, Henle W. Epstein—Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Int J Cancer 1976; 17: 1–17.

    Article  PubMed  CAS  Google Scholar 

  8. Baskies AM, Chretien PB, Yan CS, et al. Serum glycoproteins and immunoglobulins in nasopharyngeal carcinoma: correlations with Epstein-Barr virus associated antibodies and clinical tumor stage. Am J Surg 1979; 138: 478–488.

    Article  PubMed  CAS  Google Scholar 

  9. Pearson GR, Weiland LH, Neel HB. Application of Epstein-Barr virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinoma. Cancer 1983; 51: 260–268.

    Article  PubMed  CAS  Google Scholar 

  10. Sam CK, Prasad U, Pathamanathan R. Serological markers in the diagnosis of histopathological types of nasopharyngeal carcinoma. Eur J Surg Oncol 1989; 15: 357–360.

    PubMed  CAS  Google Scholar 

  11. Chen JY, Chen CJ, Liu MY et al. Antibodies to Epstein-Barr virus-specific Dnase in patients with nasopharyngeal carcinoma and control groups. J Med Virol 1987; 23: 11–21.

    Article  PubMed  CAS  Google Scholar 

  12. Littler E, Newman W, Arrand JR. Immunological response of nasopharyngeal carcinoma patients to the Epstein-Barr virus coded thymidine kinase expressed in Escherichia coli. Int J Cancer 1990; 45: 1028–1032.

    Article  PubMed  CAS  Google Scholar 

  13. Nonoyama M, Pagano, J. Homology between Epstein-Barr virus DNA and viral DNA from Burkitt’s lymphoma and nasopharyngeal carcinoma determined by DNA-DNA reassociation kinetics. Nature 1973; 242: 44–47.

    Article  PubMed  CAS  Google Scholar 

  14. Wolf H, zur Hausen H, Becker Y. EBV viral genomes in epithelial nasopharyngeal carcinoma cells. Nat Biol 1973; 244: 245–267.

    CAS  Google Scholar 

  15. Desgranges C, Wolf H, de, The G et al. Nasopharyngeal carcinoma X. Presence of Epstein-Barr virus genomes in epithelial cells of tumors from high and medium risk areas. Int J Cancer 1975; 16: 7–15.

    Article  PubMed  CAS  Google Scholar 

  16. Raab-Traub N, Flynn K, Pearson G, et al. The differentiated form of nasopharyngeal carcinoma contains Epstein-Barr virus DNA. Int J Cancer 1987; 39: 25–29.

    Article  PubMed  CAS  Google Scholar 

  17. Chao TY, Chow KC, Chang JY, et al. Expression of Epstein-Barr virus-encoded RNAs as a marker for metastatic undifferentiated nasopharyngeal carcinoma. Cancer 1996; 78: 24–29.

    Article  PubMed  CAS  Google Scholar 

  18. Niedobitek G, Hansmann MI, Herbst H, et al. Epstein-Barr virus and carcinomas: undifferentiated carcinomas but not squamous cell carcinomas of the nasopharynx are regularly associated with the virus. J Pathol 1991; 165: 17–24.

    Article  PubMed  CAS  Google Scholar 

  19. Pathmanathan R, Prasad U, Chandrika G, et al. Undifferentiated, nonkeratinizing, and squamous cell carcinoma of the nasopharynx. Variants of Epstein-Barr virus-infected neoplasia. Am J Pathol 1995; 146: 1355–1367.

    PubMed  CAS  Google Scholar 

  20. Stanley R. Clinical presentation and diagnosis. In: Chong VFH, Tsao SY (eds). Nasopharyngeal Carcinoma. Singapore, Armour, 1997.

    Google Scholar 

  21. Busson P, Ganem G, Flores P, Mugneret F, Clausse B, Caillou B, Braham K, Wakasugi H, Lipinski M, Tursz T. Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas. Int J Cancer 1988; 42: 599–606.

    Article  PubMed  CAS  Google Scholar 

  22. Raab-Traub N, Hood R, Yang CS, et al. Epstein-Barr virus transcription in nasopharyngeal carcinoma. J Virol 1983; 48: 580–590.

    PubMed  CAS  Google Scholar 

  23. Raab-Traub N, Flynn K. The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986; 47: 883–889.

    Article  PubMed  CAS  Google Scholar 

  24. Kieff E. Epstein-Barr virus and its replication. In: Fields BN, Knipe DM, Howley PM, Chanock RM, Melnick JL, Monath TP, Roizman B, Straus SE (eds). Virology. Philadelphia: Lippincott-Raven, 1996, pp. 2343–2396.

    Google Scholar 

  25. Kaschka-Dierich C, Adams A, Lindahl T, et al. Intracellular forms of Epstein-Barr virus DNA in human tumor cells in vivo. Nature 1976; 260: 302–306.

    Article  PubMed  CAS  Google Scholar 

  26. Given D, Yee D, Griem K, Kieff, E. DNA of Epstein-Barr virus. V. Direct repeats at the ends of Epstein-Barr virus DNA. J Virol 1979; 30: 852–862.

    PubMed  CAS  Google Scholar 

  27. Kripalani-Joshi S, Law HY. Identification of integrated Epstein-Barr virus in nasopharyngeal carcinoma using pulse field gel electrophoresis. Int J Cancer 1994; 56: 187–192.

    Article  PubMed  CAS  Google Scholar 

  28. Busson P, McCoy R, Sadler R, et al. Consistent transcription of the Epstein-Barr virus LMP2 gene in nasopharyngeal carcinoma. J Virol 1992; 66: 3257–3262.

    PubMed  CAS  Google Scholar 

  29. Gilligan K, Sato H, Rajadurai P, et al. Novel transcription from the Epstein-Barr virus terminal EcoR1 fragment, DlJhet, in a nasopharyngeal carcinoma. J Virol 1990; 64: 4948–4956.

    PubMed  CAS  Google Scholar 

  30. Gilligan K, Rajadurai P, Lin JC, et al. Expression of the Epstein-Barr virus BamHI A fragment in nasopharyngeal carcinoma: evidence for a viral protein preferentially expressed in epithelial cells. J Virol 1991; 65: 6252–6259.

    PubMed  CAS  Google Scholar 

  31. Hitt MM, Allday MJ, Hara T, Karran L, Jones MD, Busson P, Tursz T, Ernberg I, Griffin BE. EBV gene expression in an NPC-related tumor. EMBO J 1989; 8: 2639–2651.

    PubMed  CAS  Google Scholar 

  32. Sadler RH, Raab-Traub N. Structural analyses of the Epstein-Ban virus BamHI A transcripts. J Virol 1995; 69: 1132–1141.

    PubMed  CAS  Google Scholar 

  33. Smith PR, Gao Y, Karran L, et al. Complex nature of the major viral polyadenylated transcripts in Epstein-Barr virus-associated tumors. J Virol 1993; 67: 3217–3225.

    PubMed  CAS  Google Scholar 

  34. Fahraeus R, Fu JL, Ernberg I, Finke I, Rowe M, Klein G, Falk K, Nilsson E, Yadav M, Busson P, Tursz T, Kallin B. Expression of Epstein-Ban virus-encoded proteins in nasopharyngeal carcinoma. Int J Cancer 1988; 42: 329–338.

    Article  PubMed  CAS  Google Scholar 

  35. Young L, Dawson C, Clark D, et al. Epstein-Barr virus expression in nasopharyngeal carcinoma. J Gen Virol 1988; 69: 1051–1065.

    Article  PubMed  CAS  Google Scholar 

  36. Stewart JP, Arrand JR. Expression of the Epstein-Barr virus latent membrane protein in nasopharyngeal carcinoma biopsy specimens. Hum Pathol 1993; 24: 239–242.

    Article  PubMed  CAS  Google Scholar 

  37. Cochet C, Martel-Renoir D, Grunewald V, et al. Expression of Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells. Virology 1993; 197: 358–365.

    Article  PubMed  CAS  Google Scholar 

  38. Fries KL, Sculley TB, Webster-Cyriaque J, et al. Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus. J. Virol 1997; 71: 2765–2771.

    PubMed  CAS  Google Scholar 

  39. Laux G, Dugrillon F, Eckert C, et al. Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes. J Virol 1994; 68: 6947–6958.

    PubMed  CAS  Google Scholar 

  40. Sung NS, Kenney S, Gutsch D, et al. EBNA2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus. J Virol 1991; 65: 2164–2169.

    PubMed  CAS  Google Scholar 

  41. Wang F, Tsang SF, Kurilla M, et al. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. J Virol 1990; 54: 3407–3416.

    Google Scholar 

  42. Harada S, Kieff E. Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation. J Virol 1997; 71: 6611–6618.

    PubMed  CAS  Google Scholar 

  43. Robertson ES, Grossman S, Johannsen E, et al. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA binding protein, Jk. J Virol 1995; 69: 3108–3116.

    PubMed  CAS  Google Scholar 

  44. Smith PR, Griffin BE. Transcription of Epstein-Barr virus gene EBNA-1 from different promoters in nasopharyngeal carcinoma and B-lymphoblastoid cells. J Virol 1992; 66: 706–714.

    PubMed  CAS  Google Scholar 

  45. Sample J, Brooks L, Sample C, et al. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc Natl Acad Sci USA 1991; 88: 6343–6347. 39.

    Google Scholar 

  46. Schaeffer BC, Woisetschlaeger M, Strominger JL, et al. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes. Proc Natl Acad Sci USA 1991; 88: 6550–6554.

    Article  Google Scholar 

  47. Ernberg I, Falk K, Minarovits J, et al. The role of methylation in the phenotype-dependent modulation of Epstein-Barr nuclear antigen 2 and latent membrane protein genes in cells latently infected with Epstein-Barr virus. J Virol 1989; 70: 2989–3002.

    Article  CAS  Google Scholar 

  48. Sadler RH, Raab-Traub N. The Epstein-Barr virus 3.5 kilobase latent membrane protein 1 mRNA initiates from a TATA-less promoter within the first terminal repeat. J Virol 1995; 69: 4577–4581.

    PubMed  CAS  Google Scholar 

  49. Srinivas SK, Sixbey J. Epstein-Barr virus induction of recombinase-activating genes RAG1 and RAG2. J Virol 1995; 69: 8155–8158.

    PubMed  CAS  Google Scholar 

  50. Wilson J, Bell JL, Levine AJ. Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. EMBO J 1996; 15: 3117–3126.

    PubMed  CAS  Google Scholar 

  51. Webster-Cyriaque J, Raab-Traub N. Transcription of Epstein-Barr virus latent cycle genes in oral hairy leukoplakia. Virology 1998; 248: 53–65.

    Article  PubMed  CAS  Google Scholar 

  52. Levitskaya J, Coram M, Levitsky V, et al. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1. Nature 1995; 375: 685–688.

    Article  PubMed  CAS  Google Scholar 

  53. Kaye K, Izumi K, Kieff E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc Natl Acad Sci USA 1993; 90: 9150–9154.

    Article  PubMed  CAS  Google Scholar 

  54. Wang D, Liebowitz D, Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell 1985; 43: 831–840.

    Article  PubMed  CAS  Google Scholar 

  55. Fries K, Miller WE, Raab-Traub N. Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene. J Virol 1996; 70: 8653–8659.

    PubMed  CAS  Google Scholar 

  56. Kulwichit W, Edwards RH, Davenport E, et al. Expression of the Epstein-Barr virus latent membrane protein 1 induces B-cell lymphoma in transgenic mice. Proc Natl Acad Sci USA 1998; 95: 11963–11968.

    Article  PubMed  CAS  Google Scholar 

  57. Dawson CW, Rickinson AB, Young LS. Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation. Nature 1990; 344: 777–780.

    Article  PubMed  CAS  Google Scholar 

  58. Fahraeus R, Chen W, Trivedi P, et al. Decreased expression of E-cadherin and increased invasive capacity in EBV-LMP-transfected human epithelial and murine adenocarcinoma cells. Int J Cancer 1992; 52: 834–838.

    Article  PubMed  CAS  Google Scholar 

  59. Wilson JB, Weinberg W, Johnson R, et al. Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 1990; 61: 1315–1327.

    Article  PubMed  CAS  Google Scholar 

  60. Miller WE, Earp HS, Raab-Traub N. The Epstein-Ban virus latent membrane protein 1 induces expression of the epidermal growth factor receptor. J Virol 1995; 69: 4390–4398.

    PubMed  CAS  Google Scholar 

  61. Hu LF, Chen F, Zhen QF, et al. Differences in growth pattern and clinical course of EBV-LMP1 expressing and non-expressing nasopharyngeal carcinomas. Eur J Cancer 1995; 31: 658–660.

    Article  Google Scholar 

  62. Miller WE, Edwards RH, Walling DM, et al. Sequence variation in the Epstein-Barr virus latent membrane protein 1. J Gen Virol 1993; 75: 2729–2740.

    Article  Google Scholar 

  63. Mosialos G, Birkenbach M, Yalamanchili R, et al. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 1995; 80: 389–399.

    Article  PubMed  CAS  Google Scholar 

  64. Huen DS, Henderson SA, Croom-Carter D, et al. The Epstein-Ban virus latent membrane protein 1 (LMP1) mediates activation of NFkB and cell surface phenotype via two effector regions in its carboxy terminal cytoplasmic domain. Oncogene 1995; 10: 549–560.

    PubMed  CAS  Google Scholar 

  65. Eliopoulos AG, Young LS. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). Oncogene 1998; 16: 1731–1742.

    Article  PubMed  CAS  Google Scholar 

  66. Paine E, Scheinman RI, Baldwin Jr AS, et al. Expression of LMP1 in epithelial cells leads to the activation of a select subset of NF-iB/Rel family proteins. J Virol 1995; 69: 4572–4576.

    PubMed  CAS  Google Scholar 

  67. Miller WE, Cheshire JL, Raab-Traub N. Interaction of Tumor Necrosis factor signaling proteins with the latent membane protein PxQxt motif is essential for induction of epidermal growth factor receptor expression. Mol Cell Biol 1998; 18: 2835–2844.

    PubMed  CAS  Google Scholar 

  68. Frech B, Zimber-Strobl U, Yip TTC, et al. Characterization of the antibody response to the latent infection terminal proteins of Epstein-Barr virus in patients with nasopharyngeal carcinoma. J Gen Virol 1993; 74: 811–818.

    Article  PubMed  CAS  Google Scholar 

  69. Longnecker R, Kieff E. A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1. J Virol 1990; 64: 2319–2326.

    PubMed  CAS  Google Scholar 

  70. Miller CL, Lee JH, Kieff E, et al. An integral membrane protein (LMP2) blocks reactivationof Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proc Natl Acad Sci USA 1994; 91: 772–776.

    Article  PubMed  CAS  Google Scholar 

  71. Scholle F, Longnecker R, Raab-Traub N. Epithelial cell adhesion to extracellular matrix proteins induces tyrosine phosphorylation of the Epstein-Barr virus latent membrane protein 2: a role for C-terminal src kinase. J Virol 1999; 73: 4767–4775.

    PubMed  CAS  Google Scholar 

  72. Brooks L, Yao QY, Rickinson AB, Young LS. Epstein-Barr virus latent gene expression in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts. J Virol 1992; 66: 2689–2697.

    PubMed  CAS  Google Scholar 

  73. Arrand JR, Rymo L. Characterization of the major Epstein-Barr virus-specific RNA in Burkitt lymphoma-derived cells. J Virol 1982; 41: 376–389.

    PubMed  CAS  Google Scholar 

  74. Swaminathan S, Tomkinson B, Kieff E. Recombinant Epstein-Barr virus deleted for small RNA (EBER) genes transforms lymphocytes and replicates in vitro. Proc Natl Acad Sci USA 1991; 88: 1546–1550.

    Article  PubMed  CAS  Google Scholar 

  75. Tsai ST, Jin YT, Su IJ, Expression of EBER1 in primary and metastatic nasopharyngeal carcinoma tissues using in situ hybridization: a correlation with WHO histologic subtypes. Cancer 1996; 77: 231–236.

    Article  PubMed  CAS  Google Scholar 

  76. Gilligan K, Rajadurai P, Resnick L, et al. Epstein-Barr virus small nuclear RNAs are not expressed in permissively infected cells in AIDS-associated leukoplakia. Proc Natl Acad Sci USA 1990; 87: 8790–8794.

    Article  PubMed  CAS  Google Scholar 

  77. Raab-Traub N, Pritchett R, Kieff E. DNA of Epstein-Barr virus. III. Identification of restriction enzyme fragments which contain DNA sequences which differ among strains of EBV. J Virol 1978; 27: 388–398.

    PubMed  CAS  Google Scholar 

  78. Sato H, Takimoto T, Hatano M, et al. Epstein-Barr virus with transforming and early-antigen inducing ability originating from nasopharyngeal carcinoma. J Gen Virol 1989; 70: 717–727.

    Article  PubMed  CAS  Google Scholar 

  79. Rowe M, Young L, Cadwallader K, et al. Distinction between Epstein-Barr virus type-A (EBNA-2A) and type-B (EBNA-2B) isolates extends to the EBNA-3 family of nuclear proteins. J Virol 1989; 63: 1031–1039.

    PubMed  CAS  Google Scholar 

  80. Sample J, Young L, Martin B, et al. Epstein-Barr virus type 1 and type 2 differ in their EBNA3A, EBNA-3B and EBNA-3C genes. J Virol 1990; 64: 4084–4092.

    PubMed  CAS  Google Scholar 

  81. Walling D, Edmiston SN, Sixbey, JW, et al. Coinfection with multiple strains of the Epstein-Barr virus in human immunodeficiency virus-associated hairy leukoplakia. Proc Natl Acad Sci USA 1992; 89: 6560–6564.

    Article  PubMed  CAS  Google Scholar 

  82. Lung M, Chang R, Huang M, et al. Epstein-Barr virus genotypes associated with nasopharyngeal carcinoma in southern China. Virology 1990; 177: 44–53.

    Article  PubMed  CAS  Google Scholar 

  83. Abdel-Hamid M, Chen JJ, Constantine N, et al. EBV strain variation: geographical distribution and relation to disease state. Virology 1992; 190: 168–175.

    Article  PubMed  CAS  Google Scholar 

  84. Hu LF, Zabarovsky ER, Chen F, et al. Isolation and sequencing of the Epstein-Barr virus BNLF-1 (LMP1) from a Chinese nasopharyngeal carcinoma. J Gen Virol 1991; 72: 2399–2409.

    Article  PubMed  CAS  Google Scholar 

  85. Sample J, Kieff EF, Kieff ED. Epstein-Barr virus types 1 and 2 have nearly identical LMP-1 transforming genes. J Gen Virol 1994; 75: 2741–2746.

    Article  PubMed  CAS  Google Scholar 

  86. Knecht H, Bachmann E, Brousset P, et al. Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin’s disease and identical to those observed in nasopharyngeal carcinoma. Blood 1993; 82: 2937–2942.

    PubMed  CAS  Google Scholar 

  87. Li SN, Chang YS, Liu ST. Effect of a 10 amino acid deletion on the oncogenic activity of latent membrane protein 1 of Epstein Barr virus. Oncogene 1996; 12: 2129–2135.

    PubMed  CAS  Google Scholar 

  88. Miller WE, Cheshire JL, Baldwin AS, et al. The NPC derived C15 LMP1 protein confers enhanced activation of NF-KB and induction of the EGFR in epithelial cells. Oncogene 1998; 16: 1869–1877.

    Article  PubMed  CAS  Google Scholar 

  89. Edward RH, Seillier-Moiseiwitsch F, Raab-Traub N. Signature amino acid changes in LMP1 distinguish Epstein-Barr virus strains. Virology 1999; 261: 79–95.

    Article  Google Scholar 

  90. Walling DM, Shebib N, Weaver SC, et al. The molecular epidemiology and evolution of Epstein-Barr virus: sequence variation and genetic recombination in the latent membrane protein 1. J Infect Dis 1999; 179: 763–774

    Article  PubMed  CAS  Google Scholar 

  91. Sixbey J, Vesterinen EH, Nedrud JG, et al. EBV replication in human epithelial cells infected in vitro. Nature 1983; 306: 480–483.

    Article  PubMed  CAS  Google Scholar 

  92. Li QX, Young LS, Niedobitek G, et al. Epstein-Barr virus infection and replication in a human epithelial cell system. Nature 1992; 356: 347–350.

    Article  PubMed  CAS  Google Scholar 

  93. Imai, S, Nishikawa, J, Takada, K. Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Viro! 1998; 72: 4371–4378.

    CAS  Google Scholar 

  94. Sixbey JW, Yao QY. Immunoglobulin A-induced shift of Epstein-Barr virus tissue tropism. Science 1992; 255: 1578–1580.

    Article  PubMed  CAS  Google Scholar 

  95. Gan YJ, Chodosh J, Morgan A, et al. Epithelial cell polarization is a determinant in the infectious outcome of immunoglobulin A-mediated entry by Epstein-Barr virus. J Virol 1997; 71: 519–526.

    PubMed  CAS  Google Scholar 

  96. Zhang Q, Gutsch D, Kenney S. Functional and physical interaction between p.53 and BZLFI: implications for Epstein-Barr virus latency. Mol Cell Biol 1994; 14: 1929–1938.

    Article  PubMed  CAS  Google Scholar 

  97. Wei MX, Moulin JC, Decaussin G, et al. Expression and tumorigenicity of the Epstein-Barr virus BARF1 gene in human Louckes B-lymphocyte line. Cancer Res 1994; 54: 1843–1848.

    PubMed  CAS  Google Scholar 

  98. Lemon SM, Hutt LM, Shaw JE, et al. Replication of EBV in epithelial cells during infectious mononucleosis. Nature 1977; 268: 268–270.

    Article  PubMed  CAS  Google Scholar 

  99. Sixbey J, Nedrud JG, Raab-Traub N, et al. Detection of Epstein-Barr virus DNA and RNA in human pharyngeal epithelial cells. N Engl J Med 1984; 310: 1225–1230.

    Article  PubMed  CAS  Google Scholar 

  100. Wolf H, Haus M, Wilmes E. Persistence of Epstein-Barr virus in the parotid gland. J Virol 1984; 51: 795–798.

    PubMed  CAS  Google Scholar 

  101. Wen S, Mizugaki Y, Shinozaki F, et al. Epstein-Barr virus (EBV) infection in salivary gland tumors: lytic EBV infection in non-malignant epithelial cells surrounded by EBV-positive T-lymphoma cells. Virology 1997; 227: 484–487.

    Article  PubMed  CAS  Google Scholar 

  102. Tao Q, Srivastava G, Chan ACL. Evidence for lytic infection by Epstein-Barr virus in mucosal lymphocytes instead of nasopharyngeal epithelial cells in normal individuals. J Med Virol 1995; 45: 71–77.

    Article  PubMed  CAS  Google Scholar 

  103. Desgrange C, Bornkam GW, Zeng Y, et al. Detection of Epstein-Barr viral DNA internal repeats in the nasopharyngeal mucosa of Chinese with IgA/EBV-specific antibodies. Int J Cancer 1982; 29: 87–91.

    Article  Google Scholar 

  104. Yeung WM, Zong YS, Chiu CT, et al. Epstein-Barr virus carriage by nasopharyngeal carcinoma in situ. Int J Cancer 1993; 53: 746–750.

    Article  PubMed  CAS  Google Scholar 

  105. Pathmanathan R, Prasad U, Sadler RH, Flynn K, Raab-Traub N. Preinvasive neoplasia of the nasopharynx: a clonal proliferation of EBV-infected cells. N Engl J Med 1995; 333: 695–698.

    Article  Google Scholar 

  106. Armstrong RW, Armstrong MH, Yu MC, et al. Salted fish and inhalants as risk factors for carcinoma in Malaysian Chinese. Cancer Res 1983; 43: 2967–2970

    PubMed  CAS  Google Scholar 

  107. Ning JP, Yu MC, Wang QS, Henderson BE. Consumption of salted fish and other risk factors for nasopharyngeal carcinoma in Tianjink, a low risk region of China. J Natl Cancer Inst 1990; 82: 291–296.

    Article  PubMed  CAS  Google Scholar 

  108. Poirier S, Ohshima H, De The G, Hubert A, Bourgade MC, Bartsch H. Volatiale nitrosamine levels in common foods from Tunisia, South China, and Greenland, high risk areas for nasopharyngeal carcinoma (NPC). Int J Cancer 1987; 39: 292–296.

    Article  Google Scholar 

  109. Lanier AP, Henle W, Bender TR, et al. Nasopharyngeal carcinoma in Alaskan Eskimos, Indians, and Aleuts: a review of cases and study of Epstein-Barr virus, HLA, and environmental risk factors. Cancer 1980; 46: 2100–2106.

    Article  PubMed  CAS  Google Scholar 

  110. Lu SJ, Degos NE, Lepage V, et al. Linkage of a nasopharyngeal susceptibility locus to the HLA region. Nature 1990; 346: 470–471.

    Article  PubMed  CAS  Google Scholar 

  111. Murray PG, Niedibitek G, Kremmer E, et al. Identification of target antigens for the human cytotoxic T-cell response to Epstein-Barr virus (EBV): implications for the immune control of EBV-positve malignancies. J Exp Med 1992; 176: 157–168.

    Article  PubMed  CAS  Google Scholar 

  112. Burt RD, Vaughan TL, Nisperos B, et al. A protective association between the HLA-A2 antigen and nasopharyngeal carcinoma in US Caucasians. Int J Cancer 1994; 56: 465–467.

    Article  PubMed  CAS  Google Scholar 

  113. Eifert P, McCoy R, Abdel-Hamid M, Flynn K, et al. Alterations of the p53 gene in nasopharyngeal carcinoma. J Virol 1992; 66: 3768–3775.

    Google Scholar 

  114. Sun Y, Hegameyer G, Colburn N. Nasopharyngeal carcinoma shows no detectable retinoblastoma susceptibility gene alterations. Oncogene 1993; 8: 791–795.

    PubMed  CAS  Google Scholar 

  115. Sun Y, Hildesheim A, Lanier AP, et al. No point mutation but decreased expression of the p16/MTS1 tumor suppressor gene in nasopharyngeal carcinoma. Oncogene 1995; 10: 765–788.

    Google Scholar 

  116. Niedobitek G, Agathanggelou A, Barber P, et al. Overexpression and Epstein—Barr virus infection in undifferentiated and squamous cell nasopharyngeal carcinomas. J Pathol 1993; 170: 457–461.

    Article  PubMed  CAS  Google Scholar 

  117. Okan I, Wang Y, Chen F, et al. The EBV-encoded LMP1 protein inhibits p53-triggered apoptosis but not growth arrest. Oncogene 1995; 11: 1027–1031.

    PubMed  CAS  Google Scholar 

  118. Henderson S, Rowe M, Gregory C, et al. Induction of bd-2 expression by Epstein—Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991; 65: 1107–1115.

    Article  PubMed  CAS  Google Scholar 

  119. Lu QL, Elia G, Lucas S, et al. Bd-2 proto-oncogene expression in Epstein—Ban-virus-associated nasopharyngeal carcinoma. Int J Cancer 1993; 53: 29–35.

    Article  PubMed  CAS  Google Scholar 

  120. Huang D, Lo KW, Choi PHK, et al. Loss of heterozygosity on the short arm of chromosome 3 in nasopharyngeal carcinoma. Cancer Genet Cytogenet 1991; 54: 91–99.

    Article  PubMed  CAS  Google Scholar 

  121. Huang D, Lo KW, van Hasselt A, et al. A region of homozygous deletion on chromosome 9p21–22 in primary nasopharyngeal carcinoma. Cancer Res. 1994; 54: 4003–4006.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Nancy Raab-Traub
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Viral Epidemiology Branch, National Cancer Institute, 6120 Executive Blvd., Room 8012, MSC 7248, 20852, Rockville, MD, USA

    James J. Goedert MD (Chief) (Chief)

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media New York

About this chapter

Cite this chapter

Raab-Traub, N. (2000). Epstein-Barr Virus and Nasopharyngeal Carcinoma. In: Goedert, J.J. (eds) Infectious Causes of Cancer. Infectious Disease. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-024-7_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-024-7_6

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-4684-9621-5

  • Online ISBN: 978-1-59259-024-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation